RAPSYDO
DEAD

Serial Number

90708335

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

May 13, 2021

Add to watchlist:

No watchlists yet
View on USPTO

RAPSYDO Trademark

Serial Number: 90708335

RAPSYDO is a trademark filed by NOVARTIS AG on May 13, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,135 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 13, 2021

Registration Date

Not Registered

Published for Opposition

March 1, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Drug delivery devices, namely, injection devices for pharmaceuticals, injection devices for administering drugs

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 15, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 15, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 14, 2024 EXRA
SOU EXTENSION 5 GRANTED
Oct 14, 2024 EX5G
SOU EXTENSION 5 FILED
Oct 14, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Oct 14, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 24, 2024 EXRA
SOU EXTENSION 4 GRANTED
Apr 23, 2024 EX4G
SOU EXTENSION 4 FILED
Apr 23, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 23, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 17, 2023 EXRA
SOU EXTENSION 3 GRANTED
Oct 13, 2023 EX3G
SOU EXTENSION 3 FILED
Oct 13, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 13, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 18, 2023 EXRA
SOU EXTENSION 2 GRANTED
Apr 16, 2023 EX2G
SOU EXTENSION 2 FILED
Apr 16, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 16, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 7, 2022 EXRA
SOU EXTENSION 1 GRANTED
Oct 5, 2022 EX1G
SOU EXTENSION 1 FILED
Oct 5, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 5, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 26, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 1, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 1, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 9, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 21, 2022 CNSA
ASSIGNED TO EXAMINER
Jan 21, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 12, 2021 NWOS
NEW APPLICATION ENTERED
May 17, 2021 NWAP